UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 300

Sortiert nach

Use of Severity Grades to Characterize Histopathologic Changes

Toxicologic pathology, 2018-04, Vol.46 (3), p.256-265

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1–34)

Regulatory toxicology and pharmacology, 2017-06, Vol.86, p.356-365

2017

Link zum Volltext

Verfügbarkeit prüfen

Bone Neoplasms in F344 Rats Given Teriparatide [rhPTH(1-34)] Are Dependent on Duration of Treatment and Dose

Toxicologic pathology, 2004-07, Vol.32 (4), p.426-438

2004

Link zum Volltext

Verfügbarkeit prüfen

Skeletal Changes in Rats Given Daily Subcutaneous Injections of Recombinant Human Parathyroid Hormone (1-34) for 2 Years and Relevance to Human Safety

Toxicologic pathology, 2002-05, Vol.30 (3), p.312-321

2002

Link zum Volltext

Verfügbarkeit prüfen

Neoplastic and Non-neoplastic Changes in F-344 Rats Treated with Naveglitazar, a γ-Dominant PPAR α/γ Agonist

Toxicologic pathology, 2009-10, Vol.37 (6), p.741-753

2009

Link zum Volltext

Verfügbarkeit prüfen

p53 +/- Hemizygous Knockout Mouse: Overview of Available Data

Toxicologic pathology, 2001, Vol.29 (1_suppl), p.30-50

2001

Link zum Volltext

Verfügbarkeit prüfen

Chronic Toxicity and Carcinogenicity Studies of the Long-Acting GLP-1 Receptor Agonist Dulaglutide in Rodents

Endocrinology (Philadelphia), 2015-07, Vol.156 (7), p.2417-2428

2015

Link zum Volltext

Verfügbarkeit prüfen

Alternative Mouse Models for Carcinogenicity Assessment: Industry Use and Issues with Pathology Interpretation

Toxicologic pathology, 2010-01, Vol.38 (1), p.43-50

2010

Link zum Volltext

Verfügbarkeit prüfen

Apparent Mesonephric Duct (Rete Anlage) Origin for Cysts and Proliferative Epithelial Lesions in the Mouse Ovary

Toxicologic pathology, 2002-09, Vol.30 (5), p.592-598

Long, Gerald G.

2002

Link zum Volltext

Verfügbarkeit prüfen

Regulatory Forum Opinion Piece: Thresholds in Toxicologic Pathology

Toxicologic pathology, 2012-10, Vol.40 (7), p.1079-1081

2012

Link zum Volltext

Verfügbarkeit prüfen

Commentary on “Evaluation of Possible Carcinogenic Risk to Humans Based on Liver Tumors in Rodent Assays: The Two-Year Bioassay Is No Longer Necessary

Toxicologic pathology, 2010-04, Vol.38 (3), p.502-505

Long, Gerald G.

2010

Link zum Volltext

Verfügbarkeit prüfen

Urothelial Carcinogenesis in the Urinary Bladder of Rats Treated with Naveglitazar, a γ-dominant PPAR α/γ Agonist: Lack of Evidence for Urolithiasis as an Inciting Event

Toxicologic pathology, 2008-02, Vol.36 (2), p.218-231

2008

Link zum Volltext

Verfügbarkeit prüfen

Proliferative Lesions of Ovarian Granulosa Cells and Reversible Hormonal Changes Induced in Rats by a Selective Estrogen Receptor Modulator

Toxicologic pathology, 2001-07, Vol.29 (4), p.403-410

2001

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic Proliferative Lesions in the Spleen of rasH2 Transgenic Mice Treated with MNU

Toxicologic pathology, 2010-12, Vol.38 (7), p.1026-1036

2010

Link zum Volltext

Verfügbarkeit prüfen

Panel Discussion: Alternative Mouse Models for Carcinogenicity Assessment

Toxicologic pathology, 2010-01, Vol.38 (1), p.72-75

2010

Link zum Volltext

Verfügbarkeit prüfen

Neuronal Vacuolization and Necrosis Induced by the Noncompetitive N-methyl- d-aspartate (NMDA) Antagonist MK(+)801 (Dizocilpine Maleate): A Light and Electron Microscopic Evaluation of the Rat Retrosplenial Cortex

Experimental neurology, 1993-10, Vol.123 (2), p.204-215

1993

Link zum Volltext

Verfügbarkeit prüfen

Proliferative Lesions of Ovarian Granulosa Cells and Reversible Hormonal Changes Induced in Rats by a Selective Estrogen Receptor Modulator

Toxicologic pathology, 2001-11, Vol.29 (6), p.719-726

2001

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin Toxicity in Cats

Journal of veterinary internal medicine, 1987-01, Vol.1 (1), p.29-35

1987

Link zum Volltext

Verfügbarkeit prüfen

Precision in Data Acquisition and Reporting of Organ Weights in Rats and Mice

Toxicologic pathology, 1998-05, Vol.26 (3), p.316-318

1998

Link zum Volltext

Verfügbarkeit prüfen

The reversible effects of raloxifene on luteinizing hormone levels and ovarian morphology in mice

Reproductive toxicology (Elmsford, N.Y.), 2000, Vol.14 (1), p.37-44

2000

Link zum Volltext

Verfügbarkeit prüfen

Neoplastic and Non-neoplastic Changes in F-344 Rats Treated with Naveglitazar, a g-Dominant PPAR a/g Agonist

Toxicologic pathology, 2009-10, Vol.37 (6), p.741-753

2009

Link zum Volltext

Verfügbarkeit prüfen

Variations in animal populations over time and differences in diagnostic thresholds used can impact tumor incidence data

Toxicologic pathology, 2007-12, Vol.35 (7), p.1045

2007

Link zum Volltext

Verfügbarkeit prüfen

Letter to the Editor

Toxicologic pathology, 2007-12, Vol.35 (7), p.1045-1046

2007

Link zum Volltext

Verfügbarkeit prüfen

Letter to the Editor

Toxicologic pathology, 2007-12, Vol.35 (7), p.1045-1046

2007

Link zum Volltext

Verfügbarkeit prüfen

Letter to the Editor

Toxicologic pathology, 2007-12, Vol.35 (7), p.1045-1046

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 300

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(259)
Mit Volltextzugriff
(249)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(298)
Japanisch
(55)

Erscheinungsjahr

n.n

Thema

Science & Technology
(185)
Life Sciences & Biomedicine
(144)
Humans
(125)
Biological And Medical Sciences
(92)
Male
(87)
Female
(86)
Social Sciences
(63)
Psychology
(58)
Animals
(53)
Medical Sciences
(49)
Fundamental And Applied Biological Sciences. Psychology
(44)
Physical Sciences
(37)
Adult
(33)
Psychology. Psychoanalysis. Psychiatry
(33)
Chemistry
(30)
Psychology. Psychophysiology
(29)
Toxicology
(27)
Aged
(26)
Mice
(26)
Middle Aged
(26)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Use of Severity Grades to Characterize Histopathologic Changes

Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1–34)

Bone Neoplasms in F344 Rats Given Teriparatide [rhPTH(1-34)] Are Dependent on Duration of Treatment and Dose

Skeletal Changes in Rats Given Daily Subcutaneous Injections of Recombinant Human Parathyroid Hormone (1-34) for 2 Years and Relevance to Human Safety

Neoplastic and Non-neoplastic Changes in F-344 Rats Treated with Naveglitazar, a γ-Dominant PPAR α/γ Agonist

p53 +/- Hemizygous Knockout Mouse: Overview of Available Data

Chronic Toxicity and Carcinogenicity Studies of the Long-Acting GLP-1 Receptor Agonist Dulaglutide in Rodents

Alternative Mouse Models for Carcinogenicity Assessment: Industry Use and Issues with Pathology Interpretation

Apparent Mesonephric Duct (Rete Anlage) Origin for Cysts and Proliferative Epithelial Lesions in the Mouse Ovary

Regulatory Forum Opinion Piece: Thresholds in Toxicologic Pathology

Commentary on “Evaluation of Possible Carcinogenic Risk to Humans Based on Liver Tumors in Rodent Assays: The Two-Year Bioassay Is No Longer Necessary

Urothelial Carcinogenesis in the Urinary Bladder of Rats Treated with Naveglitazar, a γ-dominant PPAR α/γ Agonist: Lack of Evidence for Urolithiasis as an Inciting Event

Proliferative Lesions of Ovarian Granulosa Cells and Reversible Hormonal Changes Induced in Rats by a Selective Estrogen Receptor Modulator

Hematopoietic Proliferative Lesions in the Spleen of rasH2 Transgenic Mice Treated with MNU

Panel Discussion: Alternative Mouse Models for Carcinogenicity Assessment

Neuronal Vacuolization and Necrosis Induced by the Noncompetitive N-methyl- d-aspartate (NMDA) Antagonist MK(+)801 (Dizocilpine Maleate): A Light and Electron Microscopic Evaluation of the Rat Retrosplenial Cortex

Proliferative Lesions of Ovarian Granulosa Cells and Reversible Hormonal Changes Induced in Rats by a Selective Estrogen Receptor Modulator

Cisplatin Toxicity in Cats

Precision in Data Acquisition and Reporting of Organ Weights in Rats and Mice

The reversible effects of raloxifene on luteinizing hormone levels and ovarian morphology in mice

Neoplastic and Non-neoplastic Changes in F-344 Rats Treated with Naveglitazar, a g-Dominant PPAR a/g Agonist

Variations in animal populations over time and differences in diagnostic thresholds used can impact tumor incidence data

Letter to the Editor

Letter to the Editor

Letter to the Editor

Suchergebnisse filtern